CEFTIAXONE & SULBACTAM FOR INJECTION IP

CEFTIAXONE & SULBACTAM FOR INJECTION IP is a powerful, broad-spectrum antibiotic formulation designed to combat severe bacterial infections. Combining the potent activity of ceftiaxone—a third-generation cephalosporin—with the beta-lactamase inhibitor sulbactam, this injectable solution effectively targets both susceptible and resistant Gram-positive and Gram-negative bacteria. The synergistic action ensures enhanced efficacy, even against organisms that produce beta-lactamase enzymes, which typically degrade standard antibiotics. Administered intravenously or intramuscularly, CEFTIAXONE & SULBACTAM FOR INJECTION IP provides rapid therapeutic action, making it a vital choice in hospital and critical care settings for treating complicated infections such as sepsis, pneumonia, urinary tract infections, and intra-abdominal infections. With a proven safety profile and high bioavailability, this injectable formulation delivers reliable, effective treatment—offering clinicians a trusted solution in the fight against life-threatening bacterial pathogens.